Grants in Belgium
Explore grants for companies in Belgium. This directory includes national and regional funding from Belgian innovation agencies, research funders and foundations, EU and international programs open to applicants in Belgium, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Belgium come first.
Showing 1,585-1,608 of 2,093 grants
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01)
NIH · United States
Funds new analysis of clinical, genomic, environmental and registry data that already exists, to sharpen who is at risk of cancer and what happens to them.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds proof-of-concept work on a genuinely new tool, assay, platform or instrument for characterising cancer cells or handling biospecimens.
Farm Robotics Challenge
UCANR Innovate · United States
Pays student robotics teams over $100,000 combined to build AI farming solutions.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21)
NIH · United States
Funds the same reanalysis of already-collected cancer data on a smaller, exploratory footing, for teams that do not need a full research project award.
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant
NIH · United States
Funds exploratory studies of the ethical, legal and social consequences of human genetics, especially where a technology or a use of genomic data is new.
Ethical, Legal and Social Implications (ELSI) Research
NIH · United States
Funds a full research project on the ethics, law and social effects of human genetics — and refuses to review an application with no diverse-perspectives plan.
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)
NIH · United States
Funds one bundled run from first-in-human through phase 2a for a dementia drug that works on something other than amyloid or tau.
DEEPSCALE Climate Tech Accelerator
Hello Tomorrow · Global / Multinational
Supports global climate deep-tech startups scaling internationally via a Chile-based accelerator.
Vancouver Tall Challenge
Buildner Competitions · Global / Multinational
Awards $15,000 CAD to designers reimagining tall buildings for downtown Vancouver.
South Summit Brazil Startup Competition
South Summit · Spain
Offers pitch time, mentoring and investor exposure to five category-winning startups.
Tiny House 2026
Volume Zero · India
Awards $2,500 for the best Tiny House design in an open international competition.
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
NIH · United States
Funds a company and an academic group working as one team to turn an imaging, spectroscopy or data-science advance into something usable in the clinic.
Cancer Prevention and Control Clinical Trials Grant Program
NIH · United States
Funds an investigator's own cancer trial in early detection, screening, prevention, care delivery, quality of life or survivorship — not diagnosis or therapy.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21)
NIH · United States
Funds the exploratory version of the same theory-and-methods work on complex trait variation, for ideas that need testing before a larger project is justified.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21)
NIH · United States
Funds smaller, higher-risk work on how GLP-1 and related drugs change cancer risk. No clinical trial in this version.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
Personal Health Informatics for Delivering Actionable Insights to Individuals
NIH · United States
Funds informatics tools that take a person's own health data and hand back a risk assessment they can understand and do something about.
Population Approaches to Reducing Alcohol-related Cancer Risk
NIH · United States
Funds research on awareness, social norms, policy and whole-population interventions that reduce the cancer risk that comes from drinking.
Diamond Challenge
Horn Entrepreneurship · United States
Pays up to $12,000 to the winning high-school team in its $100K global pitch competition.
Translational Neural Devices
NIH · United States
Funds a therapeutic or diagnostic device for the nervous system through prototyping, safety testing, regulatory clearance and a first small clinical study.
Minor Use Minor Species Development of Drugs
FDA · United States
Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.